title: Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1.
abstract: Muscle atrophy and diaphragmatic palsy are the clinical characteristics of spinal muscular atrophy with respiratory distress type 1 (SMARD1), and are well represented in the neuromuscular degeneration (Nmd(2J) ) mouse, modeling the juvenile form of SMARD1. Both in humans and mice mutations in the IGHMBP2 gene lead to motoneuron degeneration. We could previously demonstrate that treatment with a polyethylene glycol-coupled variant of IGF1 (PEG-IGF1) improves motor functions accompanied by reduced fiber degeneration in the gastrocnemius muscle and the diaphragm, but has no beneficial effect on motoneuron survival. These data raised the question which cell autonomous disease mechanisms contribute to dysfunction and loss of Ighmbp2-deficient motoneurons. An analysis of primary Ighmbp2-deficient motoneurons exhibited differentiation deficits such as reduced spontaneous Ca(2+) transients and altered axon elongation, which was not compensated by PEG-IGF1. This points to an IGF1 independent mechanism of motoneuron degeneration that deserves treatment approaches in addition to IGF1.
authors.affiliation: Institute for Clinical Neurobiology; University of Wuerzburg; Wuerzburg, Germany.
authors.forename: Frank
authors.initials: F
authors.lastname: Krieger
authors.affiliation: Roche Pharmaceutical Research and Early Development; Roche Innovation Center Basel; F. Hoffmann-La Roche Ltd.; Basel, Switzerland.
authors.forename: Friedrich
authors.initials: F
authors.lastname: Metzger
authors.affiliation: Institute for Clinical Neurobiology; University of Wuerzburg; Wuerzburg, Germany.
authors.forename: Sibylle
authors.initials: S
authors.lastname: Jablonka
keywords: Cav2.2; IGF1; Ighmbp2; SMARD1; motoneurons
references.citation: Nature. 2006 Dec 7;444(7120):707-12
references.pmid: 17151658
references.citation: Neuron. 2001 Dec 20;32(6):1013-26
references.pmid: 11754834
references.citation: Exp Neurol. 2011 Dec;232(2):261-9
references.pmid: 21963648
references.citation: Neuron. 1998 Dec;21(6):1327-37
references.pmid: 9883726
references.citation: Int J Dev Neurosci. 1995 Apr;13(2):113-27
references.pmid: 7639096
references.citation: Acta Neuropathol. 2005 Sep;110(3):289-97
references.pmid: 16025284
references.citation: Hum Mol Genet. 2004 Sep 15;13(18):2031-42
references.pmid: 15269181
references.citation: J Biol Chem. 2011 Jun 3;286(22):19501-10
references.pmid: 21460230
references.citation: J Cell Biol. 1999 Oct 4;147(1):59-70
references.pmid: 10508855
references.citation: Neurobiol Dis. 2013 Jun;54:169-82
references.pmid: 23295857
references.citation: Hum Mol Genet. 2010 May 15;19(10):1951-66
references.pmid: 20167579
references.citation: Nat Neurosci. 2006 Oct;9(10):1247-56
references.pmid: 16980963
references.citation: Trends Biochem Sci. 2011 Jan;36(1):19-29
references.pmid: 20813532
references.citation: Hum Mol Genet. 2009 Jun 15;18(12):2115-26
references.pmid: 19299493
references.citation: J Neurosci. 2008 Jan 23;28(4):953-62
references.pmid: 18216203
references.citation: Nature. 2004 Dec 2;432(7017):580-7
references.pmid: 15577901
references.citation: J Neurosci. 2008 Mar 5;28(10):2366-74
references.pmid: 18322083
references.citation: Nat Cell Biol. 2003 Feb;5(2):87-90
references.pmid: 12563267
references.citation: Proc Natl Acad Sci U S A. 1982 Aug;79(16):4892-6
references.pmid: 6812056
references.citation: J Neurosci. 2011 Jul 6;31(27):9800-13
references.pmid: 21734271
references.citation: Mol Cell Neurosci. 2007 Jan;34(1):80-7
references.pmid: 17098443
references.citation: Hum Mutat. 2007 Aug;28(8):808-15
references.pmid: 17431882
references.citation: J Neurosci. 2010 Jan 20;30(3):849-57
references.pmid: 20089893
references.citation: Glia. 2013 Sep;61(9):1418-1428
references.pmid: 23839956
references.citation: J Neurosci. 2010 Jul 14;30(28):9349-58
references.pmid: 20631164
references.citation: J Neurobiol. 2004 Feb 5;58(2):272-86
references.pmid: 14704958
references.citation: Neuropediatrics. 2004 Jun;35(3):174-82
references.pmid: 15248100
references.citation: J Cell Biol. 2007 Oct 8;179(1):139-49
references.pmid: 17923533
references.citation: Hum Mol Genet. 2014 Apr 15;23(8):1990-2004
references.pmid: 24271012
references.citation: J Neurosci. 1987 Oct;7(10):3256-64
references.pmid: 3668626
references.citation: Channels (Austin). 2013 Jan 1;7(1):51-6
references.pmid: 23238424
references.citation: Hum Mol Genet. 2012 Aug 15;21(16):3655-67
references.pmid: 22641814
references.citation: Nat Genet. 2001 Sep;29(1):75-7
references.pmid: 11528396
references.citation: Brain. 2014 May;137(Pt 5):1374-93
references.pmid: 24681663
references.citation: J Neurosci. 2010 Aug 25;30(34):11288-99
references.pmid: 20739549
references.citation: Cell. 2010 May 14;141(4):632-44
references.pmid: 20434207
references.citation: J Neurosci. 2003 Jan 15;23(2):587-600
references.pmid: 12533619
references.citation: J Cell Biol. 2013 Sep 30;202(7):991-9
references.pmid: 24081488
references.citation: Nat Neurosci. 2006 Oct;9(10):1265-73
references.pmid: 16980965